Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

Study aims to lump hypertension, diabetes, HIV into one screening

Identifying risk factors for three leading causes of death world-wide could potentially increase treatment efficiency and drive down costs. 

So long, ACA: What President Trump means for healthcare

Healthcare’s new reality could be a return to pre-Affordable Care Act (ACA) policies and turning Medicaid into a state block grant program after Donald Trump’s upset victory in the 2016 presidential election. 

Walgreens seeks $140 million in civil lawsuit against Theranos

Walgreen Co. filed a $140 million civil lawsuit against Theranos and alleged the blood testing company breached a contract, the Wall Street Journal reports.

Thumbnail

Expert Advice: Coding Changes for Impella and What You Need to Know about Cardiac Bundles

Offered in cooperation with Abiomed

Watch this strategic webinar on the changes effective October 1, 2016, that simplify reimbursement for heart assist device systems, including Impella.

Health system agrees to pay nearly $1 million for cardiologist’s alleged improper Medicare billing

A health system in Philadelphia agreed to pay nearly $1 million to resolve allegations that a cardiologist improperly billed Medicare for unnecessary services, Philadelphia Business Journal reports.

Medicines Company stops development of investigational cardiovascular medication

After analyzing data from a recent trial, the Medicines Company announced Nov. 7 that it would stop development of MDCO-216, an investigational cholesterol efflux promoter. The company also said it would increase its investment in PCSK9i, its investigational proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor.

Strong Impella sales growth help Abiomed increase revenue 35 percent in 2Q of 2016

Abiomed’s revenue increased 35 percent to $103 million and its GAAP net income increased to $0.20 per diluted share during the second quarter of FY2017 compared with the same time period last year.

Endologix Reports Results for the Third Quarter 2016

IRVINE, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and nine months ended September 30, 2016.

Displaying 1129 - 1136 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.